The dawn of exosome-based medicine and next-generation cosmeceuticals has placed a monumental challenge before the biomanufacturing industry: scalability. Exosomes—those nanosized lipid-bilayer vesicles carrying potent biological cargo—are no longer just a research curiosity;Read More…